Literature DB >> 8586571

Loss of myelinated axons is specific to the central nervous system in a mouse model of the fetal alcohol syndrome.

S H Parson1, N M Sojitra.   

Abstract

We have previously developed a mouse model of the fetal alcohol syndrome, the outcome of which is a late loss of myelinated axons in the optic nerve of offspring of alcohol-treated mice between 9 and 15 wk of age. We have extended this study to investigate whether this axon loss is stable and specific to the central nervous system. Pregnant female (C57BL/6/Wlds x CBA) F1 mice were injected intraperitoneally with a single dose of a 25% solution of ethanol (v:w), on d 12 of gestation. Control animals were given a similar volume of saline at the same time. Litters were taken at 12 (n = 18) and 23 (n = 26) wk of age. Optic nerves only from 12-wk-old, and optic, tibial and saphenous nerves from 23-wk-old mice were removed. A systematic, random sampling method was used to estimate the cross-sectional area of whole nerves from semi thin sections, and the numbers and diameters of myelinated axons from ultrathin sections. There were no differences for the optic nerves of 12-wk-old alcohol-treated and control animals. Optic nerves from the alcohol-treated group at 23 wk had smaller cross-sectional areas and approximately 17% fewer myelinated axons than control nerves. These results confirm that axon loss occurs between 12 and 15 wk, and demonstrate that there is no additional loss of myelinated axons between 15 and 23 wk. In contrast, there were no significant differences in cross-sectional area, number of myelinated axons or axon calibre spectra for the tibial and saphenous nerves between the alcohol-treated and control groups. There was thus no evidence of a peripheral neuropathy as has been observed in chronic alcoholic subjects. In this 'binge' model of the fetal alcohol syndrome, a carefully timed dose of alcohol is administered during pregnancy to coincide with a critical period of development of the visual system. The result is a teratogenic effect which is specific to the central nervous system, stable and reproducible, with no obvious effect on the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586571      PMCID: PMC1167475     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  45 in total

1.  On the etiology of the alcoholic neurologic diseases with special reference to the role of nutrition.

Authors:  M Victor; R D Adams
Journal:  Am J Clin Nutr       Date:  1961 Jul-Aug       Impact factor: 7.045

2.  Pathological changes in peripheral nerves in experimental fetal alcohol syndrome.

Authors:  J K Baruah; D Kinder
Journal:  Alcohol Clin Exp Res       Date:  1989-08       Impact factor: 3.455

3.  Fetal ethanol exposure: a morphometric analysis of myelination in the optic nerve.

Authors:  T Samorajski; F Lancaster; R C Wiggins
Journal:  Int J Dev Neurosci       Date:  1986       Impact factor: 2.457

4.  Subclinical entrapment of the lateral femoral cutaneous nerve: an autopsy study.

Authors:  D Jefferson; R A Eames
Journal:  Muscle Nerve       Date:  1979 Mar-Apr       Impact factor: 3.217

5.  Fetal alcohol syndrome revisited.

Authors:  S Iosub; M Fuchs; N Bingol; D S Gromisch
Journal:  Pediatrics       Date:  1981-10       Impact factor: 7.124

6.  Optic nerve hypoplasia in the fetal alcohol syndrome: a mouse model.

Authors:  S H Parson; B Dhillon; G S Findlater; M H Kaufman
Journal:  J Anat       Date:  1995-04       Impact factor: 2.610

7.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

8.  Decreased axonal calibres without axonal loss in optic nerve following chronic alcohol feeding in adult rats: a morphometric study.

Authors:  C Kjellström; N G Conradi
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Alcohol and the fetus in the west of Scotland.

Authors:  J O Beattie; R E Day; F Cockburn; R A Garg
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

10.  Neuroradiological features of patients with optic nerve hypoplasia.

Authors:  S M Zeki; A S Hollman; G N Dutton
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1992 Mar-Apr       Impact factor: 1.402

View more
  6 in total

1.  Effects of early postnatal exposure to ethanol on retinal ganglion cell morphology and numbers of neurons in the dorsolateral geniculate in mice.

Authors:  Ilknur Dursun; Ewa Jakubowska-Doğru; Deborah van der List; Lauren C Liets; Julie L Coombs; Robert F Berman
Journal:  Alcohol Clin Exp Res       Date:  2011-06-08       Impact factor: 3.455

2.  Exposure of rats to a high but not low dose of ethanol during early postnatal life increases the rate of loss of optic nerve axons and decreases the rate of myelination.

Authors:  S J Harris; P Wilce; K S Bedi
Journal:  J Anat       Date:  2000-10       Impact factor: 2.610

3.  Prenatal alcohol exposure reduces magnetic susceptibility contrast and anisotropy in the white matter of mouse brains.

Authors:  Wei Cao; Wei Li; Hui Han; Shonagh K O'Leary-Moore; Kathleen K Sulik; G Allan Johnson; Chunlei Liu
Journal:  Neuroimage       Date:  2014-08-28       Impact factor: 6.556

4.  Effects of early postnatal alcohol exposure on the developing retinogeniculate projections in C57BL/6 mice.

Authors:  Ilknur Dursun; Ewa Jakubowska-Doğru; Birsen Elibol-Can; Deborah van der List; Barbara Chapman; Lihong Qi; Robert F Berman
Journal:  Alcohol       Date:  2013-02-08       Impact factor: 2.405

5.  Ethanol inhibits muscarinic receptor-induced axonal growth in rat hippocampal neurons.

Authors:  Kathryn L VanDemark; Marina Guizzetti; Gennaro Giordano; Lucio G Costa
Journal:  Alcohol Clin Exp Res       Date:  2009-08-10       Impact factor: 3.455

Review 6.  Circadian rhythms and addiction: mechanistic insights and future directions.

Authors:  Ryan W Logan; Wilbur P Williams; Colleen A McClung
Journal:  Behav Neurosci       Date:  2014-04-14       Impact factor: 1.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.